IP Library Granted Patent US 11,554,241
Granted Patent B2
US 11,554,241 · App. 15/967,209 · Granted Jan 17, 2023

Conversion of nitrogen dioxide (NO

Inventors: David R. Rounbehler (Lexington, MA); David H. Fine (Cocoa Beach, FL)
Assignee: VERO Biotech Inc.
A61M16/122A61M16/10C01B21/24A61M15/00A61M2016/1025A61M2202/0275
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,554,241
App. No.
15/967,209
Granted
Jan 17, 2023
Kind
B2
Abstract

A nitric oxide delivery system, which includes a gas bottle having nitrogen dioxide in air, converts nitrogen dioxide to nitric oxide and employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid. A nitric oxide delivery system may be used to generate therapeutic gas including nitric oxide for use in delivering the therapeutic gas to a mammal.

Claims (14)

1. A method of treating a patient with inhaled nitric oxide comprising delivering nitric oxide to a patient with an apparatus for generating therapeutic gas including nitric oxide comprising:

a first receptacle including an inlet, an outlet, and a surface-active material coated with an antioxidant, wherein the receptacle is configured to pass a flow of gaseous nitrogen dioxide in contact with the surface-active material to convert the gaseous nitrogen dioxide to nitric oxide at ambient temperature;

a second receptacle including an inlet, an outlet, and a surface-active material coated with an antioxidant, wherein the receptacle is configured to pass the flow of gaseous nitrogen dioxide in contact with the surface-active material to convert the gaseous nitrogen dioxide to nitric oxide at ambient temperature;

and a switching valve, wherein the position of the switching valve creates a fluid connection to the first receptacle inlet or the second receptacle inlet.

2. The method of claim 1 wherein the surface-active material is saturated with the aqueous solution of the antioxidant.

3. The method of claim 1 wherein the surface-active material comprises a substrate that retains water.

4. The method of claim 3 wherein the surface-active material comprises a silica gel.

5. The method of claim 1 wherein each of the first receptacle and second receptacle comprises cartridges.

6. The method of claim 1 wherein the antioxidant comprises ascorbic acid.

7. The method of claim 1 wherein the antioxidant comprises tocopherol.

8. The method of claim 1 further comprising third receptacle including an inlet, an outlet, and activated alumina, wherein the inlet of the third receptacle is configured to receive flow from the first receptacle or second receptacle and fluidly communicate the flow to the outlet of the third receptacle through the activated alumina.

9. The method of claim 1 wherein each of the first receptacle and second receptacle includes a screen and glass wool adjacent to both the inlet and the outlet.

10. The method of claim 1 further comprising a nitrogen source fluidly connected to the first receptacle outlet and to the second receptacle outlet.

11. The method of claim 10 further comprising a second switching valve fluidly connected to the second receptacle inlet.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
CHANGE OF NAME Recorded Mar 8, 2019
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 048547/0135 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2019
From: ROUNDBEHLER, DAVID R.; FINE, DAVID H.
To: GENO LLC
Reel/Frame 048287/0713 →
Continuity (9)
Continuation 14474252 · Sep 1, 2014
Continuation 13587543 · Aug 16, 2012
Continuation 13269106 · Oct 7, 2011
Continuation 12619959 · Nov 17, 2009
Continuation 11276610 · Mar 7, 2006
Continuation In Part 11206305 · Aug 18, 2005
Provisional Application 60659094 · Mar 8, 2005
Provisional Application 60602333 · Aug 18, 2004
Related Publication 20180311460A1 · Nov 1, 2018